Drug targets and lipid biomarkers of hyperlipidemia associated diseases
Hyperlipidemia (HL) is characterized by elevated level of plasma lipids affecting regular functioning of lipid-protein interactions leading to disease. The traditional lipid biomarkers utilized for detection of individuals with HL and Cardiovascular Diseases (CVD) risk, sometimes fail to predict fut...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Science Planet Inc.
2017-10-01
|
| Series: | Canadian Journal of Biotechnology |
| Online Access: | https://www.canadianjbiotech.com/CAN_J_BIOTECH/Archives/v1/Special Issue/cjb.2017-a16.pdf |